Literature DB >> 28468795

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients.

Leendert Porcelijn1, Elly Huiskes1, Martin Schipperus2, Bronno van der Holt3, Masja de Haas1,4,5,6, Jaap Jan Zwaginga5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28468795     DOI： 10.1182/blood-2016-11-751719

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.

Authors:  Etienne Crickx; Pascal Chappert; Aurélien Sokal; Sandra Weller; Imane Azzaoui; Alexis Vandenberghe; Guillaume Bonnard; Geoffrey Rossi; Tatiana Fadeev; Sébastien Storck; Jehane Fadlallah; Véronique Meignin; Etienne Rivière; Sylvain Audia; Bertrand Godeau; Marc Michel; Jean-Claude Weill; Claude-Agnès Reynaud; Matthieu Mahévas
Journal:  Sci Transl Med       Date:  2021-04-14       Impact factor: 17.956

Review 2.  How do we diagnose immune thrombocytopenia in 2018?

Authors:  John G Kelton; John R Vrbensky; Donald M Arnold
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma.

Authors:  Mengyi Du; Linlin Huang; Haiming Kou; Chenggong Li; Yu Hu; Heng Mei
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 4.  Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.

Authors:  Oriana Miltiadous; Ming Hou; James B Bussel
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

5.  Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.

Authors:  Juping Zhai; Mengyuan Ding; Tianjie Yang; Bin Zuo; Zhen Weng; Yunxiao Zhao; Jun He; Qingyu Wu; Changgeng Ruan; Yang He
Journal:  J Transl Med       Date:  2017-10-23       Impact factor: 5.531

6.  Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications.

Authors:  David E Schmidt; Katja M J Heitink-Polle; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2020-04-12       Impact factor: 5.824

Review 7.  Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Authors:  Elisa Lucchini; Francesco Zaja; James Bussel
Journal:  Haematologica       Date:  2019-05-24       Impact factor: 9.941

8.  Detection and dynamics of anti-platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia.

Authors:  Sarah Shropshire; Steven Dow; Michael Lappin
Journal:  J Vet Intern Med       Date:  2020-02-18       Impact factor: 3.333

9.  Biological stratification of clinical disease courses in childhood immune thrombocytopenia.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Bart Mertens; Leendert Porcelijn; Rick Kapur; C Ellen van der Schoot; Gestur Vidarsson; Johanna G van der Bom; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2021-03-18       Impact factor: 5.824

Review 10.  Recent advances in understanding and management of acquired thrombocytopenia.

Authors:  Srikanth Nagalla; Ravindra Sarode
Journal:  F1000Res       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.